Search research articles
Contact Us
Filters
Showing results (591-600 of 715) with videos related to
Page
of 72
Sort By:
Journal of the American Veterinary Medical Association
|
January 4, 2007
Eimeria macusaniensis infection in 15 llamas and 34 alpacas
Christopher K Cebra, Beth A Valentine, John W Schlipf, et al.
Annals of Hematology
|
July 5, 2024
FRACTION: protocol of a phase II study of Fedratinib and Nivolumab combination in patients with myelofibrosis and resistance or suboptimal response to JAK-inhibitor treatment of the German MPN study group (GSG-MPN)
Susanne Isfort, Nikolas von Bubnoff, Haifa Kathrin Al-Ali, et al.
Leukemia
|
June 2, 2022
Histone demethylase KDM4C is a functional dependency in JAK2-mutated neoplasms
Philipp Ernst, Tina M Schnöder, Nicolas Huber, et al.
Oncogene
|
March 2, 2019
Lack of CD45 in FLT3-ITD mice results in a myeloproliferative phenotype, cortical porosity, and ectopic bone formation
Anne Kresinsky, Tina M Schnöder, Ilse D Jacobsen, et al.
Journal of Cancer Research and Clinical Oncology
|
March 8, 2023
Diagnosis and treatment of MPN in real life: exploratory and retrospective chart review including 960 MPN patients diagnosed with ET or MF in Germany
Andreas Schmidt, Christiane Bernhardt, Dieter Bürkle, et al.
Journal of Thrombosis and Haemostasis : JTH
|
December 16, 2023
Aggregates of nonmuscular myosin IIA in erythrocytes associate with GATA1- and GFI1B-related thrombocytopenia
Carlo Zaninetti, Jose' Rivera, Leonard Vater, et al.
Kidney International Reports
|
July 18, 2025
Point-of-Care Anti-CD19-CAR T-cell Therapy Induces Renal Remission in Refractory Myeloperoxidase-Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis
Christian R Schultze-Florey, Vega Gödecke, Lisa Knoll, et al.
Annals of Hematology
|
July 29, 2024
MoReLife - real-life data support the potential of momelotinib as a safe and effective treatment option for cytopenic myelofibrosis patients
Stefanie Jilg, Juliana Schwaab, Katja Sockel, et al.
Signal Transduction and Targeted Therapy
|
August 28, 2025
The deacetylases HDAC1/HDAC2 control JAK2<sup>V617F</sup>-STAT signaling through the ubiquitin ligase SIAH2
Al-Hassan M Mustafa, Giuseppe Petrosino, Marten A Fischer, et al.
Nature Communications
|
March 11, 2015
Defective podocyte insulin signalling through p85-XBP1 promotes ATF6-dependent maladaptive ER-stress response in diabetic nephropathy
Thati Madhusudhan, Hongjie Wang, Wei Dong, et al.
Page
of 72
Search research articles
Search
Showing results (591-600 of 715) with videos related to
Sort By:
Page
of 72
Journal of the American Veterinary Medical Association
|
January 4, 2007
Eimeria macusaniensis infection in 15 llamas and 34 alpacas
Christopher K Cebra, Beth A Valentine, John W Schlipf, et al.
Annals of Hematology
|
July 5, 2024
FRACTION: protocol of a phase II study of Fedratinib and Nivolumab combination in patients with myelofibrosis and resistance or suboptimal response to JAK-inhibitor treatment of the German MPN study group (GSG-MPN)
Susanne Isfort, Nikolas von Bubnoff, Haifa Kathrin Al-Ali, et al.
Leukemia
|
June 2, 2022
Histone demethylase KDM4C is a functional dependency in JAK2-mutated neoplasms
Philipp Ernst, Tina M Schnöder, Nicolas Huber, et al.
Oncogene
|
March 2, 2019
Lack of CD45 in FLT3-ITD mice results in a myeloproliferative phenotype, cortical porosity, and ectopic bone formation
Anne Kresinsky, Tina M Schnöder, Ilse D Jacobsen, et al.
Journal of Cancer Research and Clinical Oncology
|
March 8, 2023
Diagnosis and treatment of MPN in real life: exploratory and retrospective chart review including 960 MPN patients diagnosed with ET or MF in Germany
Andreas Schmidt, Christiane Bernhardt, Dieter Bürkle, et al.
Journal of Thrombosis and Haemostasis : JTH
|
December 16, 2023
Aggregates of nonmuscular myosin IIA in erythrocytes associate with GATA1- and GFI1B-related thrombocytopenia
Carlo Zaninetti, Jose' Rivera, Leonard Vater, et al.
Kidney International Reports
|
July 18, 2025
Point-of-Care Anti-CD19-CAR T-cell Therapy Induces Renal Remission in Refractory Myeloperoxidase-Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis
Christian R Schultze-Florey, Vega Gödecke, Lisa Knoll, et al.
Annals of Hematology
|
July 29, 2024
MoReLife - real-life data support the potential of momelotinib as a safe and effective treatment option for cytopenic myelofibrosis patients
Stefanie Jilg, Juliana Schwaab, Katja Sockel, et al.
Signal Transduction and Targeted Therapy
|
August 28, 2025
The deacetylases HDAC1/HDAC2 control JAK2<sup>V617F</sup>-STAT signaling through the ubiquitin ligase SIAH2
Al-Hassan M Mustafa, Giuseppe Petrosino, Marten A Fischer, et al.
Nature Communications
|
March 11, 2015
Defective podocyte insulin signalling through p85-XBP1 promotes ATF6-dependent maladaptive ER-stress response in diabetic nephropathy
Thati Madhusudhan, Hongjie Wang, Wei Dong, et al.
Page
of 72